Protocol for a multisite, parallel-group, randomized clinical trial comparing a brief tele-cognitive behavioral therapy intervention (BRIGHT) with attention control for the reduction of body image-related distress among head and neck cancer survivors
Contemporary Clinical Trials · 2025
DOI: 10.1016/j.cct.2025.107888 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2025. Verfasst von Evan M Graboyes und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, United States of America; Department of Pub…. Hauptthemen laut MEDLINE: Body Image, Cancer Survivors, Cognitive Behavioral Therapy, Head and Neck Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
One in four head and neck cancer (HNC) survivors experience clinically significant body image distress (BID), a devastating psychosocial morbidity that adversely affects quality of life. To date, effective interventions for these patients are lacking. BRIGHT (Building a Renewed ImaGe after Head and neck cancer Treatment), a brief cognitive behavioral treatment (CBT), has shown potential efficacy as a novel treatment paradigm for HNC survivors with BID. The primary objective of this randomized clinical trial (RCT) is to test the hypothesis that BRIGHT improves BID among HNC survivors relative to an Attention Control (AC) intervention. In this multisite RCT, N = 180 HNC survivors with BID will be randomized 1:1 to six weeks of BRIGHT or AC of dose and delivery-matched survivorship education. Outcomes are assessed at baseline and 2, 3, 6, and 9-months post-randomization. The primary endpoint is the IMAGE-HN (Inventory to Measure and Assess imaGe disturbancE-Head and Neck) score, a validated patient-reported outcome of HNC-related BID. Secondary endpoints include the HN Shame and Stigma Scale, the PROMIS SF v1.0-Depression 8a, Anxiety 8a, and Ability to Participate in Social Activities 8a, the Beck Scale for Suicidal Ideation, and the EORTC QLQ-HN35 Trouble with Social Eating and Trouble with Social Contact subscales. The trial will also evaluate whether the effect of BRIGHT on BID is mediated through improvements in automatic thinking and body image coping strategies. Findings from this multisite RCT will provide a rigorous test of the efficacy of BRIGHT as the first evidence-based strategy to manage BID among HNC survivors. TRIAL REGISTRATION ID: NCT05442957.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, United States of America; Department of Public Health Sciences, Medical University of South Carolina, Charleston,…
- Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States of America; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United Stat…
- Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States of America; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States of Americ…
- Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, United States of America.
- Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
- Henry Ford Health Cancer Institute, Henry Ford Medical Group, Detroit, MI, United States of America.
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- National Institutes of Health National Cancer Institute
- National Center for Advancing Translational Sciences
- National Institutes of Health
- Hollings Cancer Center, Medical University of South Carolina
- Medical University of South Carolina
Zitieren
APA
Graboyes, E. M., Maurer, S. N., Kistner-Griffin, E., Armeson, K., Starr, E., McLeod, T., Balliet, W. E., Doenges, J., Slavin-Spenny, O., Vanderlan, J. R., Day, A., Pipkorn, P., Puram, S. V., Tam, S. H., Ruggiero, K. J., & Sterba, K. R. (2025). Protocol for a multisite, parallel-group, randomized clinical trial comparing a brief tele-cognitive behavioral therapy intervention (BRIGHT) with attention control for the reduction of body image-related distress among head and neck cancer survivors. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2025.107888
Vancouver
Graboyes EM, Maurer SN, Kistner-Griffin E, Armeson K, Starr E, McLeod T, et al. Protocol for a multisite, parallel-group, randomized clinical trial comparing a brief tele-cognitive behavioral therapy intervention (BRIGHT) with attention control for the reduction of body image-related distress among head and neck cancer survivors. Contemporary Clinical Trials. 2025. doi:10.1016/j.cct.2025.107888
BibTeX
@article{Graboyes2025,
author = {Graboyes, Evan M and Maurer, Stacey N and Kistner-Griffin, Emily and Armeson, Kent and Starr, Ella and McLeod, Taylor and Balliet, Wendy E and Doenges, Jacquelyn and Slavin-Spenny, Olga and Vanderlan, Jessica R and Day, Andrew and Pipkorn, Patrik and Puram, Sidharth V and Tam, Samantha H and Ruggiero, Kenneth J and Sterba, Katherine R},
title = {Protocol for a multisite, parallel-group, randomized clinical trial comparing a brief tele-cognitive behavioral therapy intervention (BRIGHT) with attention control for the reduction of body image-related distress among head and neck cancer survivors},
journal = {Contemporary Clinical Trials},
year = {2025},
doi = {10.1016/j.cct.2025.107888}
}
EUVIMED